Liquidity has been bolstered by a significant $1.7 billion working capital inflow in 2026Q1, supporting a free cash flow margin of 6.8%.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Cash from Operations | 7.18B | 5.09B | 154M | 8.05B | 6.26B | 4.21B | 5.5B | 1.48B | 1.23B | 1.49B | 1.85B | 658M | 1.22B | 382.53M | 278.69M | 261.7M | 168.93M | 248.19M | 221.98M | 202.24M | 195.03M | 74.05M | 99.41M | 56M | 39.66M | 30.19M | 13.46M |
| Operating CF Margin % | - | 2.61% | 0.09% | 5.23% | 4.33% | 3.34% | 4.95% | 1.99% | 2.05% | 3.08% | 4.56% | 2.89% | 7.39% | 3.52% | 3.44% | 5.02% | 3.8% | 6.05% | 6.6% | 7.3% | 8.56% | 4.92% | 9.93% | 7.28% | 8.59% | 9.24% | 6.08% |
| Operating CF Growth % | 533.58% | 3203.9% | -98.09% | 28.62% | 48.89% | -23.59% | 271.07% | 20.18% | -17.13% | -19.56% | 181.31% | -46.2% | 219.72% | 37.26% | 6.49% | 54.91% | -31.94% | 11.81% | 9.76% | 3.7% | 163.39% | -25.51% | 77.51% | 41.2% | 31.37% | 124.31% | - |
| Net Income | -6.44B | -6.68B | 3.29B | 2.7B | 1.2B | 1.34B | 1.79B | 1.31B | 894M | 808M | 561M | 357M | 264M | 165.72M | -11.29M | 108.36M | 98.27M | 86.25M | 83.5M | 73.4M | -43.63M | 55.63M | 44.31M | 33.27M | 25.62M | 12.89M | 7.73M |
| Depreciation & Amortization | 932M | 1.27B | 1.24B | 1.29B | 1.55B | 1.48B | 1.26B | 643M | 495M | 361M | 278M | 111M | 89M | 67.42M | 65.87M | 58.33M | 52M | 44M | 35.41M | 27.81M | 20.6M | 13.07M | 10.01M | 6.45M | 2.56M | 1.85M | 1.03M |
| Stock-Based Compensation | 154M | 204M | 212M | 216M | 234M | 203M | 281M | 177M | 145M | 135M | 148M | 71M | 48M | 36.66M | 25.33M | 18.17M | 13.87M | 14.63M | 15.33M | 15.78M | 14.9M | 4.97M | 650K | 188K | 0 | 0 | 0 |
| Deferred Taxes | -13M | -60M | 13M | -78M | -631M | -132M | -51M | 55M | -129M | -108M | 92M | -17M | -42M | -2.29M | -14.44M | 2.03M | 10.32M | 3.7M | 1.29M | -10.22M | -6.69M | 1.79M | -1.64M | 772K | -574K | -37K | 0 |
| Other Non-Cash Items | 9.93B | 9.52B | -91M | 546M | 1.71B | -54M | 25M | 301M | 1B | -1M | -12M | -6M | 586M | 154M | 8.67M | 8.2M | -9.01M | -141K | 7.53M | -265K | 88.27M | 8.98M | 40.37M | -3.3M | 79K | 43K | 548K |
| Working Capital Changes | 2.63B | 823M | -4.51B | 3.37B | 2.19B | 1.38B | 2.19B | -1B | -171M | 294M | 784M | 142M | 864M | 115.03M | 204.56M | 66.6M | 3.48M | 99.76M | 78.92M | 95.74M | 121.58M | -10.39M | 5.7M | 18.62M | 11.97M | 15.83M | 4.15M |
| Change in Receivables | -2.01B | 1.48B | -4.33B | -2.38B | -1.63B | -2.45B | -52M | -1.08B | -1.17B | -50M | 74M | -360M | -463M | -142.98M | -116.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Change in Payables | 5.02B | -657M | -528M | 3.4B | 421M | 1.14B | 0 | -421M | -533M | 53M | 402M | 39M | 506M | 151.71M | -21.47M | 38.89M | 37.4M | -60.91M | 75.11M | 31.23M | 28.14M | -4.21M | 6.48M | 22.62M | 15.6M | -1.99M | 0 |
| Cash from Investing | 1.07B | 453M | -1.05B | -1.28B | -2.92B | -3.3B | -6.96B | -1.53B | -4.58B | -1.26B | -2.4B | -813M | -848M | -342.1M | -187.91M | -129.08M | -210.61M | -270.09M | -153.92M | -225.46M | -150.26M | -56.45M | -122.48M | -140.74M | -79.68M | 2.67M | -14.62M |
| Capital Expenditures | -832M | -767M | -644M | -799M | -1B | -910M | -869M | -730M | -675M | -422M | -306M | -150M | -103M | -67.83M | -82.14M | -73.71M | -118.56M | -83.11M | -65.16M | -53.94M | -50.32M | -26.91M | -25.01M | -19.16M | -3.92M | -3.63M | -642K |
| CapEx % of Revenue | 0.42% | 0.39% | 0.39% | 0.52% | 0.69% | 0.72% | 0.78% | 0.98% | 1.12% | 0.87% | 0.75% | 0.66% | 0.62% | 0.62% | 1.01% | 1.41% | 2.67% | 2.03% | 1.94% | 1.95% | 2.21% | 1.79% | 2.5% | 2.49% | 0.85% | 1.11% | 0.29% |
| Acquisitions | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 19M | -22M | 0 | 0 | 12M | 0 | 7M | 0 | 0 | 0 | 0 | 13.42M | 1.48M | 0 | 14.1M | -66.77M | -55.48M | -86.74M | 0 | -595K | 14.74M | 0 |
| Cash from Financing | -2.42B | -1.6B | -2.41B | -1.57B | -4.2B | 1.36B | 260M | 6.81B | 4.69B | -16M | 2.72B | 294M | 192M | 145.63M | 192.81M | 6.1M | 120.35M | 46.55M | 42.46M | 20.76M | 78.91M | 45.66M | 42.84M | 89.43M | 10.81M | 36.99M | -2.35M |
| Debt Issued (Net) | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | -426M | -438M | -3.08B | -1.59B | -3.03B | -297M | -626M | -75M | 2.71B | -65M | -63M | -40M | -21M | 4.43M | 3.17M | 8.01M | 104.73M | 7.28M | -18.16M | -4.08M | -880K | 5.62M | 4.07M | 81.31M | 10.81M | 40.99M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -463M | -475M | -3.12B | -1.63B | -3.1B | -297M | -626M | -75M | -71M | -65M | -63M | -53M | -29M | -19.78M | -12.74M | -7.81M | -3.22M | -6.3M | -23.51M | -9.54M | -7.83M | 0 | 0 | 0 | 0 | -102K | 0 |
| Other Financing | -6M | -19M | -6M | 0 | -41M | -102M | -34M | 16M | 9M | 5M | -14M | -4M | 19M | 6.38M | 11M | 4.43M | -6.42M | -3.12M | 3.1M | -5.18M | 2.79M | -413K | -493K | -462K | 0 | 0 | 0 |
| Net Change in Cash | 5.7B | 3.83B | -3.13B | 5.12B | -1.04B | 2.32B | -1.32B | 6.78B | 1.27B | 142M | 2.17B | 150M | 635.7M | 228.37M | 172.24M | 139.78M | 32.96M | 21.85M | 110.52M | -2.46M | 123.69M | 147.36M | 0 | 4.69M | -29.21M | 69.84M | -3.51M |
| Free Cash Flow | 6.35B | 4.32B | -490M | 7.25B | 5.26B | 3.29B | 4.63B | 753M | 559M | 1.07B | 1.54B | 508M | 1.12B | 314.69M | 196.55M | 187.99M | 50.38M | 165.08M | 156.82M | 148.3M | 144.71M | 47.14M | 74.4M | 36.84M | 35.74M | 26.55M | 12.82M |
| FCF Margin % | 3.2% | 2.22% | -0.3% | 4.71% | 3.64% | 2.62% | 4.17% | 1.01% | 0.93% | 2.21% | 3.8% | 2.23% | 6.76% | 2.9% | 2.42% | 3.61% | 1.13% | 4.02% | 4.66% | 5.36% | 6.35% | 3.13% | 7.43% | 4.79% | 7.74% | 8.13% | 5.79% |
| FCF Growth % | 325.34% | 981.84% | -106.75% | 37.99% | 59.54% | -28.9% | 515.4% | 34.7% | -47.61% | -30.94% | 204.13% | -54.64% | 255.9% | 60.11% | 4.55% | 273.17% | -69.48% | 5.27% | 5.74% | 2.48% | 206.99% | -36.64% | 101.96% | 3.07% | 34.6% | 107.19% | - |
| FCF per Share | 12.80 | 8.80 | -0.94 | 13.29 | 9.03 | 5.58 | 8.00 | 1.79 | 1.40 | 3.02 | 4.71 | 2.06 | 4.65 | 1.40 | 0.91 | 0.90 | 0.25 | 0.93 | 0.88 | 0.83 | 0.84 | 0.26 | 0.43 | 0.24 | 0.26 | 0.28 | 0.16 |
| FCF Conversion (FCF/Net Income) | -0.98x | -0.76x | 0.05x | 2.98x | 5.21x | 3.12x | 3.04x | 1.12x | 1.37x | 1.80x | 3.29x | 1.85x | 4.51x | 2.32x | 139.35x | 2.35x | 1.78x | 2.97x | 2.66x | 2.76x | -4.47x | 1.33x | 2.24x | 1.68x | 1.55x | 2.34x | 1.74x |
| Interest Paid | 475M | 0 | 688M | 688M | 657M | 658M | 725M | 374M | 323M | 237M | 165M | 55M | 40M | 30M | 22M | 27.38M | 17.3M | 15.43M | 15.31M | 11.95M | 0 | 3.29M | 494K | 176K | 0 | 0 | 0 |
| Taxes Paid | 514M | 0 | 1B | 883M | 1.2B | 678M | 1.19B | 612M | 448M | 496M | 556M | 328M | 237M | 85M | 43M | 50.44M | 53.94M | 52.93M | 36.8M | 7.35M | 0 | 31.29M | 20.52M | 19.93M | 0 | 0 | 0 |
Regulatory and medical trend volatility
As reported in recent financial statements, Centene's operating cash flow to net income ratio reached 2.34 in 2026Q1, illustrating a significant disconnect between accounting profits and actual cash generation that warrants careful scrutiny regarding the sustainability of current earnings quality.
The wide variance between net income and operating cash flow suggests that non-cash charges and working capital fluctuations are heavily distorting the company's reported profitability. Investors should monitor whether this divergence is a temporary byproduct of the Value Creation Plan or a persistent feature of the company's accrual-heavy business model.
Based on the provided cash flow data, Centene's free cash flow margin reached 6.8% in 2026Q1, a notable recovery from the negative margins observed in late 2024, yet the historical inconsistency suggests that cash generation remains highly sensitive to operational restructuring and medical loss ratio volatility.
The erratic trajectory of free cash flow indicates that the company's ability to convert revenue into cash is frequently interrupted by lumpy capital requirements and shifting medical benefit expenses. This instability makes it difficult to rely on current cash flow levels as a baseline for long-term valuation.
According to the latest quarterly filings, Centene experienced a $1.7 billion working capital inflow in 2026Q1, which significantly bolstered cash reserves, though this follows periods of substantial outflows that highlight the inherent volatility in managing government-sponsored healthcare payment cycles.
The sharp swings in working capital suggest that the timing of state-level premium payments and medical claim settlements creates significant noise in the quarterly cash flow statement. Analysts should interpret these fluctuations as a reflection of the company's complex administrative burden rather than a fundamental shift in operational efficiency.
Based on reported figures, Centene has prioritized share repurchases, with $1.2 billion deployed in 2024Q3, while simultaneously navigating a complex restructuring phase that has limited the consistency of capital returns to shareholders over the observed ten-quarter period.
The aggressive use of cash for share buybacks during periods of operational stress appears to be a management attempt to signal confidence, yet it may conflict with the need to maintain liquidity for potential regulatory or medical trend shocks. The lack of dividend payments suggests that management remains focused on growth and deleveraging rather than direct income distribution.
Quick answers to the most common questions about buying CNC stock.
Centene Corporation (CNC) generated $5.09B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Centene Corporation (CNC) generated $4.32B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Centene Corporation (CNC) spent $767.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Centene Corporation (CNC) spent $475.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.